Emkay Taps & Cut (EMKAYTOOLS)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Latest quarter shows positive net profit of ₹2 Cr on sales of ₹32 Cr, indicating some recent operating traction
• Promoter holding of 74.99% aligns majority owners with minority shareholders
• Small market cap of ₹106 Cr leaves room for meaningful growth if fundamentals improve
• Sales growth of 3818.29% suggests a possible surge in demand or a very low base effect worth investigating

Concerns

• Piotroski F-Score of 3/9 signals poor financial health and weak earnings quality
• ROCE of -0.35% means the company is not creating value on its capital
• Profit growth of -93.32% with zero dividend offers no earnings consistency or cash return
• P/E is 0.00 and book value, debt/equity, and ROE are unavailable, making a Graham-style valuation impossible

AI Analysis

When I look at Emkay Taps & Cut, I first ask whether the business earns a satisfactory return on capital. Here the answer is troubling: ROCE is -0.35%, and the reported P/E is 0.00, which tells me trailing earnings are either missing or unreliable. The profit figure collapsed by 93.32% even though sales grew 3818.29%. In my experience, that combination is a warning sign—it often means a low base, one-time revenue, or a loss of pricing power. The latest quarter does show sales of ₹32 Cr and net profit of ₹2 Cr, so there may be a pulse, but one quarter is not an economic franchise. The Piotroski F-Score of 3/9 reinforces my caution; it points to weak financial health. There is no dividend, so as a minority shareholder I receive no return while I wait. Promoter holding of 74.99% is a positive—those who run it have skin in the game—but it also means minority shareholders have little say. The 52-week range of ₹83.10 to ₹198.00 and market cap of ₹106 Cr tell me this is a small, volatile industrial stock. I cannot calculate a margin of safety because book value, debt/equity, and ROE are not available. With no reliable earnings power, I cannot value it as a going concern. This may be a possible turnaround if the latest quarter's profit becomes repeatable and returns turn positive, but the evidence so far is too thin and too poor. As Graham said, price is what you pay, value is what you get. At ₹121.50, I don't yet know what value I would be getting. I would prefer to sit this out until more data appears.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer